Key Metrics of Bausch & Lomb
Revenue₹45,843 Cr▲ 11.8% YoYFY 2025-26
EBITDA₹4,799 Cr▼ 6.2% YoY
Net profit−₹3,235 Cr▼ 19.2% YoY
Net worth₹57,948 Cr▲ 4.6% YoY
Market cap$7.3BBLCO · $20.40
Competitors10identified
About Bausch & Lomb
Sectors
Company details
- Website
- bausch.com
- Founded
- 2022
- Listed
- NYSE: BLCO (since 2022)
Operational Areas of Bausch & Lomb
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameBausch + Lomb Corporation
TickerBLCO
ExchangeNYSE
CountryUnited States
SEC CIK0001860742
Listed since2022
IndustryOphthalmic Goods
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttps://www.bausch.com
US market & SEC filings
BLCO · NYSE · SEC CIK 0001860742
Last price · 30 Oct 2026
$20.40
+0.00%
Market cap$7.3B
P/E—On FY 2023 diluted EPS
Volume3,452,043
SectorHealth CareOphthalmic Goods
Country · IPO—Listed 2022
BLCO share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricing
Premium
Financials, ratios and risk analysis
Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Credit assessment · Manufacturing
Rating Methodology – Manufacturing Companies (Mar 2025) · Consolidated accounts · FY 2025-26
Indicative long-term—
Indicative short-term—
Score—
LiquidityAdequate
DirectionStable
Ratios, pillar scores and the indicative rating are part of Premium.
Rating status
| Default | No default on record |
| Issuer cooperation | Cooperating |
| Credit enhancement | None – standalone rating |
| Information on file | 44% · missing: Capex / investment plans, Lender details, Auditor details, Shareholding pattern, Recent rating review (last 15 months) |
Indicative assessment from public data using the published methodology factors; not a credit rating.
Registered office and contact
Registered officeRochester
GSTIN—
Email—
Websitehttps://www.bausch.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Bausch & Lomb
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Similar companies
P
PACS Group Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
O
Oscar Health Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
K
Koninklijke Philips N.V. NY Registry SharesPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
L
Labcorp Holdings Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
A
Amneal Pharmaceuticals, Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Similar revenue scale · Close financial profile
U
U.S. Physical Therapy Inc.Pharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
T
Tenet HealthcarePharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
H
Healthcare Realty Trust IncorporatedPharmaceuticals & Healthcare
Same segment: Formulations & Contract Manufacturing · Close financial profile
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.